Status:
COMPLETED
Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Menopause
Postmenopausal Vaginal Atrophy
Eligibility:
FEMALE
Brief Summary
This study is conducted in Europe. The aim of this study is to investigate the self-reported impact of Vagifem® (estradiol) treatment on urogenital discomfort in women with atrophic vaginitis due to o...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Atrophic vaginitis due to estrogen deficiency
- Post-menopausal
Exclusion
Key Trial Info
Start Date :
April 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
1613 Patients enrolled
Trial Details
Trial ID
NCT01507454
Start Date
April 1 2006
End Date
November 1 2006
Last Update
February 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Mainz, Germany, 55127